Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
CLINVAR |
Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation.
|
16716659 |
2006 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in PRKAG2, the gene encoding for the γ2 subunit of 5'-AMP-activated protein kinase (AMPK), are responsible for an autosomal dominant glycogenosis with a cardiac presentation, associating hypertrophic cardiomyopathy (HCM), ventricular pre-excitation (VPE), and progressive heart block.
|
28431061 |
2017 |
Hypertrophic Cardiomyopathy
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5'-AMP-activated protein kinase, to human chromosome 7q36.
|
11112354 |
2000 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
LHGDN |
The authors describe a 38-year-old man with a new heterozygous PRKAG2 mutation (Ser548Pro) manifesting by hypertrophic cardiomyopathy, severe conduction system abnormalities, and skeletal muscle glycogenosis.
|
16487706 |
2006 |
Hypertrophic Cardiomyopathy
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3.
|
7657794 |
1995 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
CLINVAR |
Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis.
|
14519435 |
2003 |
Hypertrophic Cardiomyopathy
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.
|
27532257 |
2017 |
Hypertrophic Cardiomyopathy
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
Taken together, our data indicate that PRKAG2 mutations do not cause hypertrophic cardiomyopathy but rather lead to a novel myocardial metabolic storage disease, in which hypertrophy, ventricular pre-excitation and conduction system defects coexist.
|
11827995 |
2002 |
Hypertrophic Cardiomyopathy
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome.
|
16339829 |
2006 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
CLINVAR |
CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.
|
14722619 |
2004 |
Hypertrophic Cardiomyopathy
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
|
11371514 |
2001 |
Hypertrophic Cardiomyopathy
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway.
|
23778007 |
2013 |
Hypertrophic Cardiomyopathy
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.
|
15611370 |
2005 |
Hypertrophic Cardiomyopathy
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Human C-Lmod is located near the hypertrophic cardiomyopathy locus CMH6 on human chromosome 7q3, potentially implicating it in this disease.
|
11318603 |
2001 |
Hypertrophic Cardiomyopathy
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
[Same genotype and different phenotypes in a family with PRKAG2 gene mutation].
|
17711718 |
2007 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
CLINVAR |
Clinical Spectrum of PRKAG2 Syndrome.
|
26729852 |
2016 |
Hypertrophic Cardiomyopathy
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
|
15877279 |
2005 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutation analysis of PRKAG2 was performed by fluorescent single-strand confirmation polymorphism analysis and direct sequencing of abnormal conformers in 200 patients with HCM.
|
15766830 |
2005 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The authors describe a 38-year-old man with a new heterozygous PRKAG2 mutation (Ser548Pro) manifesting by hypertrophic cardiomyopathy, severe conduction system abnormalities, and skeletal muscle glycogenosis.
|
16487706 |
2006 |
Hypertrophic Cardiomyopathy
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.
|
11407343 |
2001 |
Hypertrophic Cardiomyopathy
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development.
|
19808419 |
2008 |
Hypertrophic Cardiomyopathy
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Hypertrophic cardiomyopathy due to PRKAG2 mutations may have a degree of cardiac hypertrophy exceeding that expected from observed amounts of glycogen deposition.
|
19787389 |
2009 |
Hypertrophic Cardiomyopathy
|
0.500 |
Biomarker
|
disease |
BEFREE |
We developed a custom DNA resequencing array that contains both strands of all coding exons (160), splice-site junctions, and 5'UTR regions of 12 genes that have been clearly implicated in HCM (MYH7, MYBPC3, TNNT2, TPM1, TNNI3, MYL3, MYL2, CSRP3, PLN, ACTC, TNNC1, and PRKAG2).
|
18409188 |
2008 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
CLINVAR |
A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia.
|
17597581 |
2007 |